Schedule 13D ownership disclosure

Can-Fite BioPharma Ltd.

Security class unavailable · CUSIP: 13471N201

Event date: 2019-08-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-19-002331
Form type
SC 13D/A
Filer
Can-Fite BioPharma Ltd.
CIK
CIK 1536196
Filed
Sep 11, 2019
Reporting period
Aug 27, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub